StockData
Utah Medical Products Inc logo

Utah Medical Products Inc (UTMD) stock

UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.02−0.34 (-0.47%)

Close on Nov 17, 2026Market cap $229.30MP/E 22.0Yield –

Utah Medical Products price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Utah Medical Products's price to sales ratio was 6.4× on Nov 11, 2026, against 4.4× a year earlier. Over the last 5 years it ranged from 4.0× to 7.6×, with a median of 5.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.4×+2.1
2025Dec 31, 20254.4×−0.1
2024Dec 31, 20244.4×−1.5
2023Dec 29, 20235.9×−1.1
2022Dec 30, 20227.1×−0.5
2021Dec 31, 20217.6×+0.3
2020Dec 31, 20207.3×+7.3
2019Dec 31, 20190.0×+0.0
2018Dec 31, 20180.0×−7.5
2017Dec 29, 20177.6×+0.7
2016Dec 30, 20166.8×+1.5
2015Dec 31, 20155.4×−0.1
2014Dec 31, 20145.5×+0.2
2013Dec 31, 20135.3×+2.1
2012Dec 31, 20123.2×+0.3
2011Dec 30, 20112.9×–

More Utah Medical Products figures

See a number that looks wrong?